W.H. Cornerstone Investments Inc. Has $723,000 Position in UnitedHealth Group Incorporated (NYSE:UNH)

W.H. Cornerstone Investments Inc. cut its position in UnitedHealth Group Incorporated (NYSE:UNH) by 6.4% during the 3rd quarter, HoldingsChannel reports. The firm owned 1,237 shares of the healthcare conglomerate’s stock after selling 85 shares during the quarter. W.H. Cornerstone Investments Inc.’s holdings in UnitedHealth Group were worth $723,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Delta Financial Group Inc. increased its stake in UnitedHealth Group by 1.0% during the 3rd quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock worth $965,000 after purchasing an additional 17 shares in the last quarter. Signature Resources Capital Management LLC boosted its stake in UnitedHealth Group by 40.0% in the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after purchasing an additional 18 shares during the period. Saxony Capital Management LLC raised its stake in shares of UnitedHealth Group by 3.5% in the 2nd quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock valued at $270,000 after purchasing an additional 18 shares during the period. GoalVest Advisory LLC lifted its stake in UnitedHealth Group by 0.6% in the 2nd quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock valued at $1,591,000 after acquiring an additional 18 shares in the last quarter. Finally, Fiduciary Group LLC grew its stake in shares of UnitedHealth Group by 0.5% during the 2nd quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock worth $1,882,000 after acquiring an additional 18 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 1.7 %

NYSE UNH opened at $557.77 on Tuesday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $608.63. The stock has a market capitalization of $515.06 billion, a PE ratio of 36.34, a PEG ratio of 1.67 and a beta of 0.58. The business has a fifty day moving average price of $581.37 and a two-hundred day moving average price of $542.90.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm’s revenue was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.56 EPS. Equities analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.51%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.72%.

Analysts Set New Price Targets

UNH has been the subject of a number of recent research reports. Cantor Fitzgerald increased their price objective on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 16th. Barclays cut their price objective on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating for the company in a report on Tuesday, October 22nd. KeyCorp started coverage on shares of UnitedHealth Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $675.00 price target for the company. UBS Group cut their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Finally, TD Cowen lifted their target price on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Four analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $615.53.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.